New Delhi, Sept. 18 -- The eye drops, topical insulin, may support corneal healing by encouraging the growth and repair of corneal cells, helping close damaged areas and protecting cells from injury.

The Indian Pharmaceutical company has announced the grant of a patent for its pioneering insulin eye drops, marking a significant milestone towards advancing indigenous pharmaceutical research and innovation in ophthalmology.

Currently at the pre-clinical stage of development, the patented insulin eye drops are being investigated as a potential novel therapeutic approach to address unmet needs in ophthalmic care.

As India's pharmaceutical industry increasingly expands its focus beyond generics towards original research, intellectual proper...